Using the Ottawa Model of Research Use to Determine Barriers and Supports for Implementing Metered Dose Inhalers

585 Words2 Pages

The Ottawa Model of Research Use (OMRU) is an interactive model developed by Logan and Graham (1998). The OMRU views research use as a dynamic process of interconnected decisions and actions by different individuals relating to each of the model elements (Logan & Graham, 1998). The OMRU includes six key elements: (1) evidence-based innovation, (2) potential adopters, (3) the practice environment, (4) implementation of interventions, (5) adoption of the innovation, (6) outcomes resulting from implementation of the innovation (Graham & Logan, 2004).
The Ottawa Model of Research Use (OMRU) offers a “comprehensive, interdisciplinary framework of elements that affect the process of health-care knowledge transfer, and is derived from theories of change, from the literature, and from a process of reflection” (Graham & Logan, 2004, p. 93). It promotes research use, and could be used by policymakers and researchers (Logan & Graham, 1998). The OMRU is an example of a planned change theory, which helps “administrators control factors that will influence the likelihood of changes occurring at the organizational level and how these changes occur” (Graham & Logan, 2004, p. 2).
The Ottawa Model of Research Use has been used in nursing to explore the barriers and supports for adoption of new innovations, describe the process of adoption of new innovation or guidelines, implement a new research based guidelines, and to increase evidence-based practice across health-care settings. The feasibility and effectiveness of using the OMRU in actual practice contexts was supported by findings from a number of studies (Scott et al., 2009; Hogan & Logan, 2004; Logan, Harrison, Graham, Dunn, & Bissonnette, 1999; Stacey, Pomey, O'Conner, & Graham, 2006).
Scott et al. (2009) used OMRU to determine the barriers and supports for implementing metered dose inhalers with spacer devices in pediatric emergency departments for acute exacerbations of asthma research. barriers and facilitators interact with each other in terms of (1) attributes of the innovation e.g., perceived ease of use, clear advantages of metered dose inhalers with spacer and cost, (2) attributes of the practice environment e.g., staffing, organizational bureaucracy, presence of a research champion, and autonomy, (3) and attributes of the individual clinicians working within the emergency departments e.g., entrenched ideas and scepticism. The main barriers to the adoption of the metered dose inhalers with spacers were Lack of leadership in the form of a research champion, perceived resistance from patients or parents, a lack of consensus about the benefits of metered dose inhalers with spacers among staff, perceived increased cost, and perceived increased workload associated with metered dose inhalers with spacers use were the most prevalent barriers.

More about Using the Ottawa Model of Research Use to Determine Barriers and Supports for Implementing Metered Dose Inhalers

Open Document